1. Home
  2. TPH vs IOVA Comparison

TPH vs IOVA Comparison

Compare TPH & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tri Pointe Homes Inc.

TPH

Tri Pointe Homes Inc.

HOLD

Current Price

$46.36

Market Cap

3.9B

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.90

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPH
IOVA
Founded
2009
2007
Country
United States
United States
Employees
N/A
975
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
1.7B
IPO Year
2012
2008

Fundamental Metrics

Financial Performance
Metric
TPH
IOVA
Price
$46.36
$3.90
Analyst Decision
Hold
Buy
Analyst Count
6
10
Target Price
$42.50
$9.11
AVG Volume (30 Days)
3.3M
17.2M
Earning Date
05-28-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
2.72
N/A
Revenue
$3,260,447,000.00
N/A
Revenue This Year
N/A
$49.14
Revenue Next Year
$10.55
$51.69
P/E Ratio
$17.04
N/A
Revenue Growth
5.76
N/A
52 Week Low
$27.90
$1.64
52 Week High
$46.62
$5.63

Technical Indicators

Market Signals
Indicator
TPH
IOVA
Relative Strength Index (RSI) 80.96 52.02
Support Level $46.26 $1.99
Resistance Level $46.61 $4.34
Average True Range (ATR) 0.12 0.45
MACD -0.45 -0.08
Stochastic Oscillator 38.16 18.54

Price Performance

Historical Comparison
TPH
IOVA

About TPH Tri Pointe Homes Inc.

Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. Its financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: